These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 12967134)
1. Revisiting ribonucleotide reductase as a target to enhance radiation and chemotherapy anti-tumor activity. Sznol M Cancer J; 2003; 9(4):247-50. PubMed ID: 12967134 [No Abstract] [Full Text] [Related]
2. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity. Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138 [TBL] [Abstract][Full Text] [Related]
4. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563 [TBL] [Abstract][Full Text] [Related]
5. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase. Nocentini G; Barzi A Pharmacol Res; 1990; 22 Suppl 1():39-40. PubMed ID: 2284243 [No Abstract] [Full Text] [Related]
6. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents. Cerqueira NM; Fernandes PA; Ramos MJ Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051 [TBL] [Abstract][Full Text] [Related]
8. Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies. Tsimberidou AM; Alvarado Y; Giles FJ Expert Rev Anticancer Ther; 2002 Aug; 2(4):437-48. PubMed ID: 12647987 [TBL] [Abstract][Full Text] [Related]
9. Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase. Iman M; Khansefid Z; Davood A Recent Pat Anticancer Drug Discov; 2016; 11(4):461-468. PubMed ID: 27670694 [TBL] [Abstract][Full Text] [Related]
10. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model. Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303 [TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells. Leyden D; Ahmed N; Hassan HT Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645 [TBL] [Abstract][Full Text] [Related]
12. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells. Myette MS; Elford HL; Chitambar CR Cancer Lett; 1998 Jul; 129(2):199-204. PubMed ID: 9719462 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ribonucleotide reductase by caracemide. Moore EC; Loo TL Cancer Treat Rep; 1984 Oct; 68(10):1293-4. PubMed ID: 6395952 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P; Lien EJ; Avramis VI Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093 [TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase. Stanziale SF; Petrowsky H; Joe JK; Roberts GD; Zager JS; Gusani NJ; Ben-Porat L; Gonen M; Fong Y Surgery; 2002 Aug; 132(2):353-9. PubMed ID: 12219034 [TBL] [Abstract][Full Text] [Related]
16. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY). Moore EC; Hurlbert RB Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152 [No Abstract] [Full Text] [Related]
17. Regulation of the ribonucleotide reductase small subunit gene by DNA-damaging agents in Dictyostelium discoideum. Gaudet P; Tsang A Nucleic Acids Res; 1999 Aug; 27(15):3042-8. PubMed ID: 10454598 [TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy. Cory JG; Sato A; Lasater L Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256 [No Abstract] [Full Text] [Related]
19. γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. Fu S; Yang Y; Das TK; Yen Y; Zhou BS; Zhou MM; Ohlmeyer M; Ko EC; Cagan R; Rosenstein BS; Chen SH; Kao J PLoS One; 2012; 7(6):e38465. PubMed ID: 22768044 [TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. Huang A; Fan H; Taylor WR; Wright JA Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]